![Daniel Javitt](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Daniel Javitt
Founder at
NeuroRx, Inc.
Net worth: 4 M $ as of 2026-05-30
Health Technology
Profile
Daniel C.
Javitt is associated with NeuroRx, Inc. as a Co-Chairman since 2015.
He is the founder of NeuroRx, Inc. which was founded in 2015.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
NRX Pharmaceuticals, Inc.
 NRX Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a molecule pharmaceutical company 4.05% | 2026-02-11 | 963,480 ( 4.05% ) | 4 M $ | 2026-05-30 |
Daniel Javitt active positions
| Companies | Position | Start |
|---|---|---|
NeuroRx, Inc.
 NeuroRx, Inc. BiotechnologyHealth Technology Develops novel therapeutics for treatment of central nervous system disorders | Founder | 2014-12-31 |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
4
1st degree connections
1
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 1 |
|---|---|
NeuroRx, Inc.
NeuroRx, Inc. BiotechnologyHealth Technology Develops novel therapeutics for treatment of central nervous system disorders | Health Technology |
- Stock Market
- Insiders
- Daniel Javitt
